Intercontinental Wealth Advisors’s Biogen BIIB Stock Holding History

Intercontinental Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$415K	Sell	1,458 -5	-0.3%	-$1.49K	0.1%	210
2023 Q1	$407K	Buy	1,463 +6	+0.4%	+$1.66K	0.1%	218
2022 Q4	$403K	Sell	1,457 -601	-29%	-$170K	0.12%	192
2022 Q3	$549K	Buy	2,058 +37	+2%	+$7.86K	0.17%	136
2022 Q2	$412K	Hold	2,021	–	–	0.11%	185
2022 Q1	$426K	Sell	2,021 -6	-0.3%	-$1.3K	0.1%	196
2021 Q4	$486K	Sell	2,027 -2	-0.1%	-$514	0.1%	187
2021 Q3	$574K	Sell	2,029 -226	-10%	-$74.1K	0.13%	149
2021 Q2	$781K	Buy	2,255 +113	+5%	+$34.2K	0.15%	109
2021 Q1	$599K	Buy	2,142 +316	+17%	+$85.2K	0.13%	138
2020 Q4	$447K	Buy	+1,826	New	+$471K	0.11%	152

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Intercontinental Wealth Advisors's BIIB Position: Q2 2023 in Review

Intercontinental Wealth Advisors reduced its Biogen (BIIB) stake by 0.34% in Q2 2023, selling an estimated $1.49K and leaving 1,458 shares worth $415K. The position accounts for 0.1% of the portfolio, ranked #210.

Intercontinental Wealth Advisors first reported a position in BIIB in Q4 2020 and has held it in 11 quarters since. The position peaked at $781K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Intercontinental Wealth Advisors held 1,458 shares of Biogen worth $415K as of Q2 2023.
Intercontinental Wealth Advisors sold 5 Biogen shares in Q2 2023, an estimated $1.49K.
Biogen made up 0.1% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #210 holding.
Intercontinental Wealth Advisors first reported a position in Biogen in Q4 2020 and has held it in 11 quarters since.
Intercontinental Wealth Advisors's Biogen position peaked at $781K in Q2 2021.
1,009 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.